Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term Comparative Study. Found 94 abstracts

no pagination
College of American P, Young NA, Moriarty AT, Walsh MK, Wang E, Wilbur DC. The potential for failure in gynecologic regulatory proficiency testing with current slide validation criteria: results from the College of American Pathologists Interlaboratory Comparison in Gynecologic Cytology Program. Archives of pathology & laboratory medicine. 2006 Aug;130(8):1114-8.
Daly MB, Axilbund JE, Bryant E, Buys S, Eng C, Friedman S, Esserman LJ, Farrell CD, Ford JM, Garber JE, Jeter JM, Kohlmann W, Lynch PM, Marcom PK, Nabell LM, Offit K, Osarogiagbon RU, Pasche B, Reiser G, Sutphen R, Weitzel JN, National Comprehensive Cancer N. Genetic/familial high-risk assessment: breast and ovarian. Journal of the National Comprehensive Cancer Network. 2006 Feb;4(2):156-76.
Wang G, Kossenkov AV, Ochs MF. LS-NMF: a modified non-negative matrix factorization algorithm utilizing uncertainty estimates. BMC Bioinformatics. 2006 Jan;7:175.
Chen ZS, Guo Y, Belinsky MG, Kotova E, Kruh GD. Transport of bile acids, sulfated steroids, estradiol 17-beta-D-glucuronide, and leukotriene C4 by human multidrug resistance protein 8 (ABCC11). Molecular Pharmacology. 2005 Feb;67(2):545-57.
Diratzouian H, Freedman GM, Hanlon AL, Eisenberg DF, Anderson PR. Importance of physical examination in the absence of a mammographic abnormality for the detection of early-stage breast cancer. Clinical Breast Cancer. 2005 Oct;6(4):330-3.
Dushkin H, Schilder RJ. Imatinib mesylate and its potential implications for gynecologic cancers. Current treatment options in oncology. 2005 Mar;6(2):115-20.
Manne SL, Ostroff JS, Winkel G, Fox K, Grana G, Miller E, Ross S, Frazier T, Buyyounouski MK, Hanlon AL, Eisenberg DF, Horwitz EM, Feigenberg SJ, Uzzo RG, Pollack A, Morrow M, Chen JQ, Yager JD, Russo J, Bassi DE, Fu J, Lopez de Cicco R, Klein-Szanto AJ, Devlin J, Sherman E, Altomare DA, Vaslet CA, Skele KL, De Rienzo A, Devarajan K, Jhanwar SC, McClatchey AI, Kane AB, Testa JR, Murphy ME, Langer CJ, Mehta MP, Viterbo R, Greenberg RE, Al-Saleem T, Canutescu AA, Dunbrack RL, Serebriiskii IG, Fang R, Latypova E, Hopkins R, Vinson C, Joung JK, Golemis EA. Couple-focused group intervention for women with early stage breast cancer. . J Consult Clin Psychol. 2005 Sep 15;73(4):634-46.
Zhang R, Poustovoitov MV, Ye X, Santos HA, Chen W, Daganzo SM, Erzberger JP, Serebriiskii IG, Canutescu AA, Dunbrack RL, Pehrson JR, Berger JM, Kaufman PD, Adams PD. Formation of MacroH2A-containing senescence-associated heterochromatin foci and senescence driven by ASF1a and HIRA. Developmental cell. 2005 Jan;8(1):19-30.
Cairns P. Detection of promoter hypermethylation of tumor suppressor genes in urine from kidney cancer patients. Ann N Y Acad Sci. 2004 Jun;1022:40-3.
Kramer NM, Horwitz EM, Uzzo RG, Hanlon AL, Hanks GE. Matched-cohort analysis of patients with prostate cancer followed with observation or treated with three-dimensional conformal radiation therapy. BJU international. 2004 Jul;94(1):59-62.
Krassenstein R, Sauter E, Dulaimi E, Battagli C, Ehya H, Klein-Szanto A, Cairns P. Detection of breast cancer in nipple aspirate fluid by CpG island hypermethylation. Clinical Cancer Research. 2004 Jan;10(1, Pt. 1):28-32.
Langer CJ. Irinotecan in advanced lung cancer: focus on North American trials. Oncology (Huntington). 2004 Jun;18(7 Suppl 4):17-28.
Milling SW, Sai T, Silvers WK, Mintz B. Inhibition of melanoma growth after treatment with dendritic cells in a Tyr-SV40E murine model requires CD4+ T cells but not CD8+ T cells. Melanoma Research. 2004 Dec;14(6):555-62.
Nordin K, Bjork J, Berglund G. Factors influencing intention to obtain a genetic test for a hereditary disease in an affected group and in the general public. Prev Med. 2004 Dec;39(6):1107-14.
Stoyanova R, Nicholson JK, Lindon JC, Brown TR. Sample classification based on Bayesian spectral decomposition of metabonomic NMR data sets. Analytical Chemistry. 2004 Jul;76(13):3666-74.
Stoyanova R, Querec TD, Brown TR, Patriotis C. Normalization of single-channel DNA array data by principal component analysis. Bioinformatics (Oxford, England). 2004 Jul 22;20(11):1772-84.
von Mehren M, Capo-Chichi CD, Rula ME, Smedberg JL, Vanderveer L, Parmacek MS, Morrisey EE, Godwin AK, Xu XX, Seeger C, Adams GP, Weiner LM, Haluszka O, Tokar JL, Greenwald BD, Tseng M, Hernandez T. Review Perception of differentiation cues by GATA factors in primitive endoderm lineage determination of mouse embryonic stem cells Salient molecular features of hepatitis C virus revealed Monoclonal antibody therapy of cancer Endoscopic oncology Comparison of intakes of US Chinese women based on food frequency and 24-hour recall data. Clinical advances in hematology & oncology : H&O. 2004 May;2(5):321.
Yeung AT, Holloway BP, Adams PS, Shipley GL. Evaluation of dual-labeled fluorescent DNA probe purity versus performance in real-time PCR. Biotechniques. 2004 Feb;36(2):266-70, 272, 274-5.
Altomare DA, Tanno S, De Rienzo A, Klein-Szanto AJ, Skele KL, Hoffman JP, Testa JR. Frequent activation of AKT2 kinase in human pancreatic carcinomas. Journal of cellular biochemistry. 2003 Jan;88(1):470-6.
Chen ZJ, Gate L, Davis W, Ile KE, Tew KD. Sensitivity and fidelity of DNA microarray improved withintegration of Amplified Differential Gene Expression (ADGE). BMC Genomics. 2003 Jul 14;4(1):28.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term Comparative Study

Comparative Study Human Female Non-US Gov't Research Support mt [Methods] Middle Aged Adult Sensitivity and Specificity ge [Genetics] pa [Pathology] Aged Reproducibility of Results Neoplasm Staging Non-US Gov't Support me [Metabolism] Male Treatment Outcome di [Diagnosis] 80 and over Aged NIH Research Support-Extramural aa [Analogs & Derivatives] st [Standards] mo [Mortality] ph [Physiology] US Gov't Support-PHS de [Drug Effects] Neoplasm Proteins metabolism Drug Dose-Response Relationship Algorithms Prognosis Breast Neoplasms diagnosis Oligonucleotide Array Sequence Analysis Antineoplastic Agents Survival Analysis Immunohistochemistry DNA Methylation analysis dt [Drug Therapy] Computer Simulation Gene Expression Regulation Gene Expression Profiling Questionnaires surgery etiology Recombinant Fusion Proteins Ovarian Neoplasms bl [Blood] Promoter Regions (Genetics) Western Blotting Time Factors 0 (Antineoplastic Agents) Tumor Suppressor Proteins Neoplasm DNA ch [Chemistry] cl [Classification] ad [Administration & Dosage] methods 0 (Recombinant Fusion Proteins) 0 (Neoplasm Proteins) Isoenzymes Genetic Screening Reverse Transcriptase Polymerase Chain Reaction pathology Amino Acid Sequence genetics Adenocarcinoma Kidney Neoplasms Retrospective Studies North America Needle Biopsy tu [Therapeutic Use] ur [Urine] 0 (Peptide Fragments) 0 (DNA-Binding Proteins) CD4-Positive T-Lymphocytes 0 (Proteins) Chi-Square Distribution Risk Assessment Immunoprecipitation Adjuvant Radiotherapy Molecular Sequence Data sn [Statistics & 0 (Indoles) 0 (Bacterial Proteins) secondary US Gov't Research Support-Non-PHS HL-60 Cells Bile Acids and Salts complications Sweden Cell Proliferation Survival Rate China 0 (Repressor Proteins) Principal Component Analysis 0 (Nuclear Proteins) 0 (Taxoids) Enzyme Activation Uterine Cervical Neoplasms Maximum Tolerated Dose Cell Count Female Genital Neoplasms Health Behavior Skin Neoplasms im [Immunology] 0 (Pyrimidines) Body Fluids Non-Histone Chromosomal Proteins Antineoplastic) 0 (Antimetabolites Ca (2+)-Calmodulin Dependent Protein Kinase human) 0 (ABCC11 protein Age Factors Adrenal Gland Neoplasms an [Analysis] LLC-PK1 Cells 72025-60-6 (Leukotriene C4) Nuclear Proteins Clinical Competence Fluorescence Resonance Energy Transfer 33419-42-0 (Etoposide) Family 0 (Cytokines) Small Cell Carcinoma 0 (Hydrazines) Base Sequence 152459-95-5 (imatinib) Ovary Drug Administration Schedule Use] Retinoic Acid Receptors Stents Dendritic Cells Transgenic Mice Lung Neoplasms Proto-Oncogene Proteins Macrophages Transcription Factors 0 (Anticonvulsants) Health Care Quality Assurance Hydrazines Inborn Genetic Diseases Attitude to Health Automated Pattern Recognition Vaginal Smears standards Asian Americans Plasmids Wistar Rats
Last updated on Saturday, July 04, 2020